Skip to main content
. 2022 Dec 31;15(1):299. doi: 10.3390/cancers15010299

Table 4.

Distribution of outcomes by stage for MDT and non-MDT patients, one and two years after diagnosis.

1 Year p-Value 2 Year p-Value
MDTYes (%) MDT No (%) MDT Yes (%) MDT No (%)
Stage 1 0.64 0.53
Disease-free 88.9 86.0 92.2 89.6
Recurrence 7.4 4.0 3.9 6.3
Recurrence ->Died 3.7 6.0 3.9 0.0
Died 0.0 4.0 0.0 4.2
Stage 2 0.62 0.72
Disease-free 75.0 81.8 100 81.8
Recurrence 25.0 9.1 0.0 9.1
Recurrence -> Died 0.0 0.0 0.0 0.0
Died 0.0 9.1 0.0 9.1
Stage 3 <0.01 <0.01
Disease-free 54.1 25.3 92.3 45.6
Recurrence 24.3 23.2 7.7 27.9
Recurrence -> Died 10.8 40.4 0.0 17.7
Died 10.8 11.1 0.0 8.8
Stage 4 0.08 0.20
Disease-free 60.0 38.8 84.2 62.5
Recurrence 0.0 4.1 0.0 5.0
Recurrence -> Died 13.3 2.0 0.0 0.0
Died 26.7 55.1 15.8 32.5
All stages <0.01 <0.01
Disease-free 67.5 46.2 90.5 65.1
Recurrence 14.5 13.2 4.1 14.8
Recurrence -> Died 8.4 20.8 1.3 7.1
Died 9.6 19.8 4.1 13.0

p-value was calculated with Fisher’s exact test or χ2-test as appropriated.